Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project.
Authors
McHugh, David M SCameron, Cynthia A
Abdenur, Jose E
Abdulrahman, Mahera
Adair, Ona
Al Nuaimi, Shahira Ahmed
Åhlman, Henrik
Allen, Jennifer J
Antonozzi, Italo
Archer, Shaina
Au, Sylvia
Auray-Blais, Christiane
Baker, Mei
Bamforth, Fiona
Beckmann, Kinga
Pino, Gessi Bentz
Berberich, Stanton L
Binard, Robert
Boemer, François
Bonham, Jim
Breen, Nancy N
Bryant, Sandra C
Caggana, Michele
Caldwell, S Graham
Camilot, Marta
Campbell, Carlene
Carducci, Claudia
Bryant, Sandra C
Caggana, Michele
Caldwell, S Graham
Camilot, Marta
Campbell, Carlene
Carducci, Claudia
Cariappa, Rohit
Carlisle, Clover
Caruso, Ubaldo
Cassanello, Michela
Castilla, Ane Miren
Ramos, Daisy E Castiñeiras
Chakraborty, Pranesh
Chandrasekar, Ram
Ramos, Alfredo Chardon
Cheillan, David
Chien, Yin-Hsiu
Childs, Thomas A
Chrastina, Petr
Sica, Yuri Cleverthon
de Juan, Jose Angel Cocho
Colandre, Maria Elena
Espinoza, Veronica Cornejo
Corso, Gaetano
Currier, Robert
Cyr, Denis
Czuczy, Noemi
D'Apolito, Oceania
Davis, Tim
de Sain-Van der Velden, Monique G
Delgado Pecellin, Carmen
Di Gangi, Iole Maria
Di Stefano, Cristina Maria
Dotsikas, Yannis
Downing, Melanie
Downs, Stephen M
Dy, Bonifacio
Dymerski, Mark
Rueda, Inmaculada
Elvers, Bert
Eaton, Roger
Eckerd, Barbara M
El Mougy, Fatma
Eroh, Sarah
Espada, Mercedes
Evans, Catherine
Fawbush, Sandy
Fijolek, Kristel F
Fisher, Lawrence
Franzson, Leifur
Frazier, Dianne M
Garcia, Luciana R C
Bermejo, Maria Sierra García-Valdecasas
Gavrilov, Dimitar
Gerace, Rosemarie
Giordano, Giuseppe
Irazabal, Yolanda González
Greed, Lawrence C
Grier, Robert
Grycki, Elyse
Gu, Xuefan
Gulamali-Majid, Fizza
Hagar, Arthur F
Han, Lianshu
Hannon, W Harry
Haslip, Christa
Hassan, Fayza Abdelhamid
He, Miao
Hietala, Amy
Himstedt, Leslie
Hoffman, Gary L
Hoffman, William
Hoggatt, Philis
Hopkins, Patrick V
Hougaard, David M
Hughes, Kerie
Hunt, Patricia R
Hwu, Wuh-Liang
Hynes, June
Ibarra-González, Isabel
Ingham, Cindy A
Ivanova, Maria
Jacox, Ward B
John, Catharine
Johnson, John P
Jónsson, Jón J
Karg, Eszter
Kasper, David
Klopper, Brenda
Katakouzinos, Dimitris
Khneisser, Issam
Knoll, Detlef
Kobayashi, Hirinori
Koneski, Ronald
Kozich, Viktor
Kouapei, Rasoul
Kohlmueller, Dirk
Kremensky, Ivo
la Marca, Giancarlo
Lavochkin, Marcia
Lee, Soo-Youn
Lehotay, Denis C
Lemes, Aida
Lepage, Joyce
Lesko, Barbara
Lewis, Barry
Lim, Carol
Linard, Sharon
Lindner, Martin
Lloyd-Puryear, Michele A
Lorey, Fred
Loukas, Yannis L
Luedtke, Julie
Maffitt, Neil
Magee, J Fergall
Manning, Adrienne
Manos, Shawn
Marie, Sandrine
Hadachi, Sônia Marchezi
Marquardt, Gregg
Martin, Stephen J
Matern, Dietrich
Mayfield Gibson, Stephanie K
Mayne, Philip
McCallister, Tonya D
McCann, Mark
McClure, Julie
McGill, James J
McKeever, Christine D
McNeilly, Barbara
Morrissey, Mark A
Moutsatsou, Paraskevi
Mulcahy, Eleanor A
Nikoloudis, Dimitris
Norgaard-Pedersen, Bent
Oglesbee, Devin
Oltarzewski, Mariusz
Ombrone, Daniela
Ojodu, Jelili
Papakonstantinou, Vagelis
Reoyo, Sherly Pardo
Park, Hyung-Doo
Pasquali, Marzia
Pasquini, Elisabetta
Patel, Pallavi
Pass, Kenneth A
Peterson, Colleen
Pettersen, Rolf D
Pitt, James J
Poh, Sherry
Pollak, Arnold
Porter, Cory
Poston, Philip A
Price, Ricky W
Queijo, Cecilia
Quesada, Jonessy
Randell, Edward
Ranieri, Enzo
Raymond, Kimiyo
Reddic, John E
Reuben, Alejandra
Ricciardi, Charla
Rinaldo, Piero
Rivera, Jeff D
Roberts, Alicia
Rocha, Hugo
Roche, Geraldine
Greenberg, Cheryl Rochman
Mellado, José María Egea
Juan-Fita, María Jesús
Ruiz, Consuelo
Ruoppolo, Margherita
Rutledge, S Lane
Ryu, Euijung
Saban, Christine
Sahai, Inderneel
García-Blanco, Maria Isabel Salazar
Santiago-Borrero, Pedro
Schenone, Andrea
Schoos, Roland
Schweitzer, Barb
Scott, Patricia
Seashore, Margretta R
Seeterlin, Mary A
Sesser, David E
Sevier, Darrin W
Shone, Scott M
Sinclair, Graham
Skrinska, Victor A
Stanley, Eleanor L
Strovel, Erin T
Jones, April L Studinski
Sunny, Sherlykutty
Takats, Zoltan
Tanyalcin, Tijen
Teofoli, Francesca
Thompson, J Robert
Tomashitis, Kathy
Domingos, Mouseline Torquado
Torres, Jasmin
Torres, Rosario
Tortorelli, Silvia
Turi, Sandor
Turner, Kimberley
Tzanakos, Nick
Valiente, Alf G
Vallance, Hillary
Vela-Amieva, Marcela
Vilarinho, Laura
von Döbeln, Ulrika
Vincent, Marie-Francoise
Vorster, B Chris
Watson, Michael S
Webster, Dianne
Weiss, Sheila
Wilcken, Bridget
Wiley, Veronica
Williams, Sharon K
Willis, Sharon A
Woontner, Michael
Wright, Katherine
Yahyaoui, Raquel
Yamaguchi, Seiji
Yssel, Melissa
Zakowicz, Wendy M
Affiliation
Mayo Clinic College of Medicine, Rochester, Minnesota, USA.Issue Date
2011-03MeSH
Amino AcidsCarnitine
Humans
Infant, Newborn
International Cooperation
Metabolic Diseases
Neonatal Screening
Reference Values
Sensitivity and Specificity
Software
Tandem Mass Spectrometry
Metadata
Show full item recordCitation
Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project. 2011, 13 (3):230-54 Genet. Med.Journal
Genetics in medicine : official journal of the American College of Medical GeneticsDOI
10.1097/GIM.0b013e31820d5e67PubMed ID
21325949Abstract
To achieve clinical validation of cutoff values for newborn screening by tandem mass spectrometry through a worldwide collaborative effort.Item Type
ArticleLanguage
enISSN
1530-0366ae974a485f413a2113503eed53cd6c53
10.1097/GIM.0b013e31820d5e67
Scopus Count
Collections
Related articles
- [Newborn screening program and blood amino acid profiling in early neonates with citrin deficiency].
- Authors: Tang CF, Liu SC, Feng Y, Mei HF, Liu HP, Feng JW, Ye LX, Wang GQ, Liu L, Huang YL
- Issue date: 2019 Oct 2
- Postanalytical tools improve performance of newborn screening by tandem mass spectrometry.
- Authors: Hall PL, Marquardt G, McHugh DM, Currier RJ, Tang H, Stoway SD, Rinaldo P
- Issue date: 2014 Dec
- Reference values of amino acids, acylcarnitines and succinylacetone by tandem mass spectrometry for use in newborn screening in southwest Colombia.
- Authors: Céspedes N, Valencia A, Echeverry CA, Arce-Plata MI, Colón C, Castiñeiras DE, Hurtado PM, Cocho JA, Herrera S, Arévalo-Herrera M
- Issue date: 2017 Sep 30
- A quantitative method for acylcarnitines and amino acids using high resolution chromatography and tandem mass spectrometry in newborn screening dried blood spot analysis.
- Authors: Miller JH 4th, Poston PA, Karnes HT
- Issue date: 2012 Aug 15
- Short-term stability of amino acids and acylcarnitines in the dried blood spots used to screen newborns for metabolic disorders.
- Authors: Golbahar J, Altayab DD, Carreon E
- Issue date: 2014 Mar
Related items
Showing items related by title, author, creator and subject.
-
Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data.Brueggemann, Angela B; Jansen van Rensburg, Melissa J; Shaw, David; McCarthy, Noel D; Jolley, Keith A; Maiden, Martin C J; van der Linden, Mark P G; Amin-Chowdhury, Zahin; Bennett, Désirée E; Borrow, Ray; et al. (2021-06)
-
Global Retinoblastoma Presentation and Analysis by National Income Level.Fabian, Ido Didi; Abdallah, Elhassan; Abdullahi, Shehu U; Abdulqader, Rula A; Adamou Boubacar, Sahadatou; Ademola-Popoola, Dupe S; Adio, Adedayo; Afshar, Armin R; Aggarwal, Priyanka; Aghaji, Ada E; et al. (2020-05)Importance: Early diagnosis of retinoblastoma, the most common intraocular cancer, can save both a child's life and vision. However, anecdotal evidence suggests that many children across the world are diagnosed late. To our knowledge, the clinical presentation of retinoblastoma has never been assessed on a global scale. Objectives: To report the retinoblastoma stage at diagnosis in patients across the world during a single year, to investigate associations between clinical variables and national income level, and to investigate risk factors for advanced disease at diagnosis. Design, setting, and participants: A total of 278 retinoblastoma treatment centers were recruited from June 2017 through December 2018 to participate in a cross-sectional analysis of treatment-naive patients with retinoblastoma who were diagnosed in 2017. Main outcomes and measures: Age at presentation, proportion of familial history of retinoblastoma, and tumor stage and metastasis. Results: The cohort included 4351 new patients from 153 countries; the median age at diagnosis was 30.5 (interquartile range, 18.3-45.9) months, and 1976 patients (45.4%) were female. Most patients (n = 3685 [84.7%]) were from low- and middle-income countries (LMICs). Globally, the most common indication for referral was leukocoria (n = 2638 [62.8%]), followed by strabismus (n = 429 [10.2%]) and proptosis (n = 309 [7.4%]). Patients from high-income countries (HICs) were diagnosed at a median age of 14.1 months, with 656 of 666 (98.5%) patients having intraocular retinoblastoma and 2 (0.3%) having metastasis. Patients from low-income countries were diagnosed at a median age of 30.5 months, with 256 of 521 (49.1%) having extraocular retinoblastoma and 94 of 498 (18.9%) having metastasis. Lower national income level was associated with older presentation age, higher proportion of locally advanced disease and distant metastasis, and smaller proportion of familial history of retinoblastoma. Advanced disease at diagnosis was more common in LMICs even after adjusting for age (odds ratio for low-income countries vs upper-middle-income countries and HICs, 17.92 [95% CI, 12.94-24.80], and for lower-middle-income countries vs upper-middle-income countries and HICs, 5.74 [95% CI, 4.30-7.68]). Conclusions and relevance: This study is estimated to have included more than half of all new retinoblastoma cases worldwide in 2017. Children from LMICs, where the main global retinoblastoma burden lies, presented at an older age with more advanced disease and demonstrated a smaller proportion of familial history of retinoblastoma, likely because many do not reach a childbearing age. Given that retinoblastoma is curable, these data are concerning and mandate intervention at national and international levels. Further studies are needed to investigate factors, other than age at presentation, that may be associated with advanced disease in LMICs.
-
ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries.Thompson, Paul M; Jahanshad, Neda; Ching, Christopher R K; Salminen, Lauren E; Thomopoulos, Sophia I; Bright, Joanna; Baune, Bernhard T; Bertolín, Sara; Bralten, Janita; Bruin, Willem B; et al. (2020-03-20)